Clindamycin-resistant Streptococcus pyogenes in Chinese children

doi:10.1016/S1473-3099(21)00699-X

Comment

. 2021 Dec;21(12):1631-1632.

doi: 10.1016/S1473-3099(21)00699-X.

Clindamycin-resistant Streptococcus pyogenes in Chinese children

Dingle Yu¹, Yunmei Liang², Yuejie Zheng³, Yonghong Yang⁴

Affiliations

¹ Microbiology Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China; Respiratory Department, Shenzhen Children's Hospital, Shenzhen 518038, China.
² Pediatrics Department, Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing, China.
³ Respiratory Department, Shenzhen Children's Hospital, Shenzhen 518038, China.
⁴ Microbiology Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China; Respiratory Department, Shenzhen Children's Hospital, Shenzhen 518038, China. Electronic address: yyh628628@sina.com.

PMID: 34838224
PMCID: PMC9760124
DOI: 10.1016/S1473-3099(21)00699-X

Comment

Clindamycin-resistant Streptococcus pyogenes in Chinese children

Dingle Yu et al. Lancet Infect Dis. 2021 Dec.

. 2021 Dec;21(12):1631-1632.

doi: 10.1016/S1473-3099(21)00699-X.

Authors

Dingle Yu¹, Yunmei Liang², Yuejie Zheng³, Yonghong Yang⁴

Affiliations

¹ Microbiology Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China; Respiratory Department, Shenzhen Children's Hospital, Shenzhen 518038, China.
² Pediatrics Department, Beijing Chaoyang Hospital affiliated to Capital Medical University, Beijing, China.
³ Respiratory Department, Shenzhen Children's Hospital, Shenzhen 518038, China.
⁴ Microbiology Laboratory, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, Beijing 100045, China; Respiratory Department, Shenzhen Children's Hospital, Shenzhen 518038, China. Electronic address: yyh628628@sina.com.

PMID: 34838224
PMCID: PMC9760124
DOI: 10.1016/S1473-3099(21)00699-X

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests. This research was funded by the Shenzhen Key Medical Discipline Construction Fund (SZXK032), the Guangdong Medical Research Fund (A2021437), the Hospital Level Project of Shenzhen Children's Hospital (ynkt2020-zz19), and the Shenzhen Fund for Guangdong Provincial High-level Clinical Key Specialties (SZGSP012). DY and YL contributed equally.

Comment on

Increasing clindamycin resistance in group A streptococcus.
White BP, Siegrist EA. White BP, et al. Lancet Infect Dis. 2021 Sep;21(9):1208-1209. doi: 10.1016/S1473-3099(21)00456-4. Lancet Infect Dis. 2021. PMID: 34450068 No abstract available.
Remdesivir, on the road to DisCoVeRy.
Gyselinck I, Janssens W. Gyselinck I, et al. Lancet Infect Dis. 2022 Feb;22(2):153-155. doi: 10.1016/S1473-3099(21)00559-4. Epub 2021 Sep 14. Lancet Infect Dis. 2022. PMID: 34534513 Free PMC article. No abstract available.

Cited by

Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation.
Babiker A, Warner S, Li X, Chishti EA, Saad E, Swihart BJ, Dekker JP, Walker M, Lawandi A, Kadri SS; NIH-Antimicrobial Resistance Outcomes Research Initiative. Babiker A, et al. Lancet Infect Dis. 2025 Mar;25(3):265-275. doi: 10.1016/S1473-3099(24)00507-3. Epub 2024 Oct 10. Lancet Infect Dis. 2025. PMID: 39396526
Pathogenesis, epidemiology and control of Group A Streptococcus infection.
Brouwer S, Rivera-Hernandez T, Curren BF, Harbison-Price N, De Oliveira DMP, Jespersen MG, Davies MR, Walker MJ. Brouwer S, et al. Nat Rev Microbiol. 2023 Jul;21(7):431-447. doi: 10.1038/s41579-023-00865-7. Epub 2023 Mar 9. Nat Rev Microbiol. 2023. PMID: 36894668 Free PMC article. Review.
Epidemiological analysis of Group A streptococcus infection diseases among children in Beijing, China under COVID-19 pandemic.
Li H, Zhou L, Zhao Y, Ma L, Zhang H, Liu Y, Liu X, Hu J. Li H, et al. BMC Pediatr. 2023 Feb 13;23(1):76. doi: 10.1186/s12887-023-03885-7. BMC Pediatr. 2023. PMID: 36782167 Free PMC article.

References

1. White BP, Siegrist EA. Increasing clindamycin resistance in group A streptococcus. Lancet Infect Dis. 2021;21:1208–1209. - PubMed
1. Fay K, Onukwube J, Chochua S, et al. Patterns of antibiotic nonsusceptibility among invasive group A streptococcus infections—United States, 2006–2017. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab575. published online June 25. - DOI - PubMed
1. Hsia Y, Lee BR, Versporten A, et al. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019;7:e861–e871. - PubMed
1. Jeong DW, Lee B, Heo S, Oh Y, Heo G, Lee JH. Two genes involved in clindamycin resistance of Bacillus licheniformis and Bacillus paralicheniformis identified by comparative genomic analysis. PLoS One. 2020;15 - PMC - PubMed
1. Isogai N, Urushibara N, Kawaguchiya M, et al. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions. Microb Drug Resist. 2013;19:298–307. - PubMed

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

[1] White BP, Siegrist EA. Increasing clindamycin resistance in group A streptococcus. Lancet Infect Dis. 2021;21:1208–1209. - PubMed

[2] White BP, Siegrist EA. Increasing clindamycin resistance in group A streptococcus. Lancet Infect Dis. 2021;21:1208–1209. - PubMed

[3] Fay K, Onukwube J, Chochua S, et al. Patterns of antibiotic nonsusceptibility among invasive group A streptococcus infections—United States, 2006–2017. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab575. published online June 25. - DOI - PubMed

[4] Fay K, Onukwube J, Chochua S, et al. Patterns of antibiotic nonsusceptibility among invasive group A streptococcus infections—United States, 2006–2017. Clin Infect Dis. 2021 doi: 10.1093/cid/ciab575. published online June 25. - DOI - PubMed

[5] Hsia Y, Lee BR, Versporten A, et al. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019;7:e861–e871. - PubMed

[6] Hsia Y, Lee BR, Versporten A, et al. Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries. Lancet Glob Health. 2019;7:e861–e871. - PubMed

[7] Jeong DW, Lee B, Heo S, Oh Y, Heo G, Lee JH. Two genes involved in clindamycin resistance of Bacillus licheniformis and Bacillus paralicheniformis identified by comparative genomic analysis. PLoS One. 2020;15 - PMC - PubMed

[8] Jeong DW, Lee B, Heo S, Oh Y, Heo G, Lee JH. Two genes involved in clindamycin resistance of Bacillus licheniformis and Bacillus paralicheniformis identified by comparative genomic analysis. PLoS One. 2020;15 - PMC - PubMed

[9] Isogai N, Urushibara N, Kawaguchiya M, et al. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions. Microb Drug Resist. 2013;19:298–307. - PubMed

[10] Isogai N, Urushibara N, Kawaguchiya M, et al. Characterization of Enterococcus faecium with macrolide resistance and reduced susceptibility to quinupristin/dalfopristin in a Japanese hospital: detection of extensive diversity in erm(B)-regulator regions. Microb Drug Resist. 2013;19:298–307. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Clindamycin-resistant Streptococcus pyogenes in Chinese children

Affiliations

Clindamycin-resistant Streptococcus pyogenes in Chinese children

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources